Estabrook Capital Management’s Celgene Corp CELG Stock Holding History

Estabrook Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-300	Closed	-$29.8K	–	357
2019 Q3	$29.8K	Hold	300	–	–	0.01%	234
2019 Q2	$27.7K	Hold	300	–	–	﹤0.01%	244
2019 Q1	$28.3K	Hold	300	–	–	﹤0.01%	242
2018 Q4	$19.2K	Hold	300	–	–	﹤0.01%	266
2018 Q3	$26.8K	Hold	300	–	–	﹤0.01%	258
2018 Q2	$23.8K	Hold	300	–	–	﹤0.01%	274
2018 Q1	$26.8K	Hold	300	–	–	﹤0.01%	267
2017 Q4	$31.3K	Hold	300	–	–	﹤0.01%	259
2017 Q3	$43.7K	Hold	300	–	–	0.01%	246
2017 Q2	$39K	Hold	300	–	–	0.01%	254
2017 Q1	$37.3K	Hold	300	–	–	0.01%	261
2016 Q4	$34.7K	Hold	300	–	–	0.01%	269
2016 Q3	$31.4K	Hold	300	–	–	﹤0.01%	274
2016 Q2	$29.6K	Hold	300	–	–	﹤0.01%	289
2016 Q1	$30K	Hold	300	–	–	﹤0.01%	282
2015 Q4	$35.9K	Hold	300	–	–	0.01%	272
2015 Q3	$32.5K	Hold	300	–	–	﹤0.01%	279
2015 Q2	$34.7K	Sell	300 -98	-25%	-$11.2K	﹤0.01%	273
2015 Q1	$45.9K	Hold	398	–	–	0.01%	273
2014 Q4	$44.5K	Hold	398	–	–	﹤0.01%	281
2014 Q3	$37.7K	Hold	398	–	–	﹤0.01%	291
2014 Q2	$34.2K	Hold	398	–	–	﹤0.01%	307
2014 Q1	$27.8K	Hold	398	–	–	﹤0.01%	323
2013 Q4	$33.6K	Hold	398	–	–	﹤0.01%	309
2013 Q3	$30.7K	Hold	398	–	–	﹤0.01%	317
2013 Q2	$23.3K	Buy	+398	New	+$23.9K	﹤0.01%	340

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Estabrook Capital Management's CELG Position: Q4 2019 in Review

Estabrook Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 300 shares — an estimated $29.8K sold.

Estabrook Capital Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $45.9K in Q1 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Estabrook Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Estabrook Capital Management sold 300 Celgene Corp shares in Q4 2019, an estimated $29.8K.
Estabrook Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
Estabrook Capital Management's Celgene Corp position peaked at $45.9K in Q1 2015.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Estabrook Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.